Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

Recruiting now

Conditions studied: Nephrolithiasis, Urosepsis

In brief

The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.

Key facts

Study ID

NCT04669886

Run by

University of Miami

People needed

150

Starts

2023-11-01

Expected to finish

2026-12-01

Last updated by the study team

2025-09-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults that is able to consent (≥ 18 years of age)
• Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals
• not currently immunosuppressed [White blood count (WBC) >= 2, not on immunosuppressive medications]

You may not qualify if…

• unable to consent and < 18 years of age
• currently immunosuppressed (WBC < 2, not on immunosuppressive medications)

Where it is running

• University of Miami — Miami, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.